Absorption, Metabolism and Excretion of [14C]-Lasmiditan - Single Oral Dose Administration

Summary

This study will be an open-label, nonrandomized, absorption, metabolism, and excretion study of \[14C\]-lasmiditan administered as a 200-milligrams (mg) (approximately 100 microcuries\[µCi\]) oral solution to 8 healthy males and females, following at least a 10 hour fast from food to assess the pharmacokinetics (PK), metabolism, and routes and extent of elimination of a single oral dose of 200 mg (approximately 100 µCi) \[14C\] lasmiditan in healthy males and females.

Timeline

Start

2017-04-20

Primary completion

2017-05-06

Completion

2017-05-06

Drugs

Indications

No indication recorded.